The Evolution of mRNA: From Pandemic Response to Cancer Treatment The global response to the COVID-19 pandemic accelerated a technological leap that is now reshaping oncology. MRNA technology, which provided the blueprint for vaccines like Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax, is moving beyond viral prevention to target some of the most challenging forms of cancer. … Read more
Obesity’s Impact on Vaccine Effectiveness: A Shift Towards Tissue-Specific Immunity For years, vaccine development has largely focused on stimulating a robust antibody response. However, emerging research suggests this approach may be less effective in individuals with obesity. A recent study published in The Journal of Immunology reveals that obesity significantly impairs the quality and longevity … Read more
Bangladesh Measles Crisis: A Warning Sign for Global Vaccine Equity The recent measles outbreak in Bangladesh, with at least 143 deaths since March 15th and over 12,000 suspected cases, is a stark reminder of the devastating consequences of declining vaccination rates. Hospitals in Dhaka, including the DNCC Hospital originally established for COVID-19, are overwhelmed with … Read more
The Looming Shadow of Resurgent Diseases: Beyond Measles The recent surge in measles cases across the United States – with over 1,671 confirmed cases reported in 2026 alone – serves as a stark warning. But measles may not be the only once-conquered foe poised for a comeback. A concerning trend is emerging with declining vaccination … Read more
Shingles Vaccine Shows Promise in Delaying Dementia: A Modern Look at the Virus-Brain Connection Emerging research suggests a surprising link between common viral infections, particularly those caused by herpesviruses, and the development of dementia. A recent study, currently available as a preprint on SSRN, indicates that vaccination against herpes zoster (shingles) and antiviral therapies may … Read more
Fresh COVID Variant “Cicada” (BA.3.2) Spreads: What You Need to Know Health officials are closely monitoring a newly emerging COVID-19 variant, BA.3.2, nicknamed “Cicada” due to its prolonged period of undetected circulation. The Centers for Disease Control and Prevention (CDC) recently published a report detailing its spread across the globe and within the United States. … Read more
A New Weapon in the Fight Against Lyme Disease: Pfizer and Valneva’s Promising Vaccine For the first time in decades, a potential Lyme disease vaccine is on the horizon. Pharmaceutical giants Pfizer and Valneva announced Monday that their vaccine candidate, PF-07307405 (formerly known as VLA15), has demonstrated over 70% efficacy in preventing Lyme disease in … Read more
The Growing Wave of Newborn Care Refusals: A Deepening Crisis of Trust A disturbing trend is emerging in hospitals across the United States: parents are increasingly refusing routine, preventative care for their newborns. Beyond vaccine hesitancy, this extends to vital interventions like vitamin K shots, eye ointment to prevent infections and even screenings for potentially … Read more
Beyond COVID-19: The Next Generation of mRNA and DNA Vaccine Technology The rapid development and deployment of mRNA vaccines during the COVID-19 pandemic marked a turning point in global healthcare. These vaccines, initially administered in December 2020, are estimated to have prevented at least 14.4 million deaths in the first year alone. This success has … Read more
Measles Resurgence: Why Holidaymakers Need to Check Their Vaccinations Health officials are urging travellers to ensure they are fully vaccinated against measles as cases surge across the UK and Europe. A recent travel advisory issued by Ireland’s Health Service Executive (HSE) highlights the growing concern, particularly ahead of the Easter holiday period. The Rising Threat … Read more